泌尿外科指南

订阅

MedSci主页 / 所有栏目 / 泌尿外科指南

2021 BAUS共识文件：长期留置导尿管并发症的管理

2021-04-03 英国泌尿外科医师学会 BJU Int.2021 Apr 3.

导尿管

2021年4月，英国泌尿外科医师学会(BAUS)发布了长期留置导尿管并发症的管理共识、长期留置导尿管的并发症包括导尿管相的尿路感染，紫色尿袋综合征，导管阻塞，膀胱痉挛，膀胱容量丧失，膀胱出扩张和慢性炎

中文标题：

2021 BAUS共识文件：长期留置导尿管并发症的管理

英文标题：

British Association of Urological Surgeons (BAUS) and Nurses (BAUN) Consensus Document: Management of the Complications of Long Term Indwelling Catheters

发布机构：

英国泌尿外科医师学会

发布日期：

2021-04-03

简要介绍：

2021年4月，英国泌尿外科医师学会(BAUS)发布了长期留置导尿管并发症的管理共识、长期留置导尿管的并发症包括导尿管相的尿路感染，紫色尿袋综合征，导管阻塞，膀胱痉挛，膀胱容量丧失，膀胱出扩张和慢性炎症等，本文主要针对长期留置导尿管并发症的管理提供共识意见。

 

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 BAUS共识文件：长期留置导尿管并发症的管理.pdf)] GetToolGuiderByIdResponse(projectId=1, id=9cb061c00208101d, title=2021 BAUS共识文件：长期留置导尿管并发症的管理, enTitle=British Association of Urological Surgeons (BAUS) and Nurses (BAUN) Consensus Document: Management of the Complications of Long Term Indwelling Catheters, guiderFrom=BJU Int.2021 Apr 3., authorId=0, author=, summary=2021年4月，英国泌尿外科医师学会(BAUS)发布了长期留置导尿管并发症的管理共识、长期留置导尿管的并发症包括导尿管相的尿路感染，紫色尿袋综合征，导管阻塞，膀胱痉挛，膀胱容量丧失，膀胱出扩张和慢性炎, cover=https://img.medsci.cn/2021410/1618059813271_2020535.jpg, journalId=0, articlesId=null, associationId=1632, associationName=英国泌尿外科医师学会, associationIntro=, copyright=0, guiderPublishedTime=Sat Apr 03 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2021年4月，英国泌尿外科医师学会(BAUS)发布了长期留置导尿管并发症的管理共识、长期留置导尿管的并发症包括导尿管相的尿路感染，紫色尿袋综合征，导管阻塞，膀胱痉挛，膀胱容量丧失，膀胱出扩张和慢性炎症等，本文主要针对长期留置导尿管并发症的管理提供共识意见。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=38736, tagName=导尿管)], categoryList=[CategoryDto(categoryId=26, categoryName=泌尿外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=38736, guiderKeyword=导尿管, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=10641, appHits=571, showAppHits=0, pcHits=1657, showPcHits=10067, likes=5, shares=47, comments=61, approvalStatus=1, publishedTime=Sat Apr 10 21:09:10 CST 2021, publishedTimeString=2021-04-03, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sat Apr 10 21:05:06 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 22:44:48 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 BAUS共识文件：长期留置导尿管并发症的管理.pdf)])
2021 BAUS共识文件：长期留置导尿管并发症的管理.pdf
下载请点击：
评论区 (43)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2181472, encodeId=f66821814e23f, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58b69144175, createdName=ms6000001186367494, createdTime=Sat Jan 13 23:16:24 CST 2024, time=2024-01-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2097829, encodeId=f3b6209e829ac, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee486463647, createdName=ms4000000158623159, createdTime=Tue Nov 01 13:48:41 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095800, encodeId=42942095800a7, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=077b4869846, createdName=10095170222, createdTime=Mon Oct 24 15:06:22 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222629, encodeId=c4901222629dd, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65db8181226, createdName=ms6000000394586292, createdTime=Thu May 26 17:48:59 CST 2022, time=2022-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230761, encodeId=8e521230e6152, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27d6494510, createdName=ms2000000287932968, createdTime=Tue Jul 05 20:47:33 CST 2022, time=2022-07-05, status=1, ipAttribution=)]
    2024-01-13 ms6000001186367494 来自浙江省

    积分

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2181472, encodeId=f66821814e23f, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58b69144175, createdName=ms6000001186367494, createdTime=Sat Jan 13 23:16:24 CST 2024, time=2024-01-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2097829, encodeId=f3b6209e829ac, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee486463647, createdName=ms4000000158623159, createdTime=Tue Nov 01 13:48:41 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095800, encodeId=42942095800a7, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=077b4869846, createdName=10095170222, createdTime=Mon Oct 24 15:06:22 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222629, encodeId=c4901222629dd, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65db8181226, createdName=ms6000000394586292, createdTime=Thu May 26 17:48:59 CST 2022, time=2022-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230761, encodeId=8e521230e6152, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27d6494510, createdName=ms2000000287932968, createdTime=Tue Jul 05 20:47:33 CST 2022, time=2022-07-05, status=1, ipAttribution=)]
    2022-11-01 ms4000000158623159

    积分

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2181472, encodeId=f66821814e23f, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58b69144175, createdName=ms6000001186367494, createdTime=Sat Jan 13 23:16:24 CST 2024, time=2024-01-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2097829, encodeId=f3b6209e829ac, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee486463647, createdName=ms4000000158623159, createdTime=Tue Nov 01 13:48:41 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095800, encodeId=42942095800a7, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=077b4869846, createdName=10095170222, createdTime=Mon Oct 24 15:06:22 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222629, encodeId=c4901222629dd, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65db8181226, createdName=ms6000000394586292, createdTime=Thu May 26 17:48:59 CST 2022, time=2022-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230761, encodeId=8e521230e6152, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27d6494510, createdName=ms2000000287932968, createdTime=Tue Jul 05 20:47:33 CST 2022, time=2022-07-05, status=1, ipAttribution=)]
    2022-10-24 10095170222

    积分

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2181472, encodeId=f66821814e23f, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58b69144175, createdName=ms6000001186367494, createdTime=Sat Jan 13 23:16:24 CST 2024, time=2024-01-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2097829, encodeId=f3b6209e829ac, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee486463647, createdName=ms4000000158623159, createdTime=Tue Nov 01 13:48:41 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095800, encodeId=42942095800a7, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=077b4869846, createdName=10095170222, createdTime=Mon Oct 24 15:06:22 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222629, encodeId=c4901222629dd, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65db8181226, createdName=ms6000000394586292, createdTime=Thu May 26 17:48:59 CST 2022, time=2022-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230761, encodeId=8e521230e6152, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27d6494510, createdName=ms2000000287932968, createdTime=Tue Jul 05 20:47:33 CST 2022, time=2022-07-05, status=1, ipAttribution=)]
    2022-05-26 ms6000000394586292

    积分

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2181472, encodeId=f66821814e23f, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58b69144175, createdName=ms6000001186367494, createdTime=Sat Jan 13 23:16:24 CST 2024, time=2024-01-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2097829, encodeId=f3b6209e829ac, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee486463647, createdName=ms4000000158623159, createdTime=Tue Nov 01 13:48:41 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095800, encodeId=42942095800a7, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=077b4869846, createdName=10095170222, createdTime=Mon Oct 24 15:06:22 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222629, encodeId=c4901222629dd, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65db8181226, createdName=ms6000000394586292, createdTime=Thu May 26 17:48:59 CST 2022, time=2022-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230761, encodeId=8e521230e6152, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27d6494510, createdName=ms2000000287932968, createdTime=Tue Jul 05 20:47:33 CST 2022, time=2022-07-05, status=1, ipAttribution=)]
    2022-07-05 ms2000000287932968

    积分

    0

以上为热门评论，梅斯医学App还有更多内容

拓展阅读

2022 NHS 临床指南：成人导尿管临床指南 (307)

NHS 大格拉斯哥和克莱德 (NHSGGC) · 2022-01-27

缓解男性患者拔除导尿管疼痛的最佳证据总结

广东省人民医院 · 2022-01-01